Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis

por Kitamura, Shigekazu, Takeshima, Takao, Yui, Daishi, da Silva Lima, Gabriel Paiva, Koukakis, Reija, Peng, Cheng, Yoshida, Ryuji, Numachi, Yotaro, Hasebe, Miki
Publicado 2023

Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial

por Hirata, Koichi, Takeshima, Takao, Sakai, Fumihiko, Numachi, Yotaro, Yoshida, Ryuji, Koukakis, Reija, Hasebe, Miki, Yui, Daishi, da Silva Lima, Gabriel Paiva, Cheng, Sunfa
Publicado 2023